Stocks-AGRX-Agile Therapeutics Inc

AGRX Agile Therapeutics Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Agile Therapeutics Inc's revenues increased by 165.40% and amounted to 10.88M. Net income increased by 66.07% to -25.41M. Net assets decreased by 159.81% to -5.55M and EPS decreased from -0.77 to -1.18.
AGRX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.75%
Net Profit Margin
-2,222.34%
Operating Margin
-113.70%
Return On Investment
-282.91%